STAT

MARCH 3, 2025

In the spring of 2009, the first flu pandemic in four decades began. The world got lucky in 2009. Caused by an H1N1 virus that emerged from pigs, likely in Mexico, it spread quickly around the globe. Read the rest…

Immunization

pharmaphorum

JUNE 26, 2025

The CDCs newly constituted Advisory Committee on Immunization Practices (ACIP) has voted to recommend the removal of vaccine preservative, thimerosal, that has become a focal point for activists trying to link vaccines to autism. Of all the issues the ACIP needs to focus on, this is not a big issue.

Vaccines

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. During the 2009–19 period, children in the US ages five years and younger accounted for 58, 000 annual RSV-related hospitalisations and 100–500 annual deaths.

Vaccines

pharmaphorum

MARCH 15, 2021

MeMed CEO Dr. Eran Eden explores the relationship between the host immune response and SARS-CoV-2 infection and how technology could help personalise treatment strategies. One of these involves listening to what the body’s own immune system can tell us. This is made possible using ‘Advanced Host Immune Response Technologies’.

Immunization

PharmaShots

FEBRUARY 21, 2023

Market Cap: $8.57M Founded Year: 2009 Total Employees: ~40 Headquarters: Oslo, Norway Stock Exchange: OSE Nordic Nanovector is a biotech company committed to developing and commercializing antibody-radionuclide conjugates to address significant unmet medical needs. In Aug’21, the US FDA cleared QSam’s IND application for CycloSam.

FDA

The Checkup by Singlecare

NOVEMBER 30, 2023

Acetaminophen may also blunt the effects of other medications that impact the immune system, including some medicines used to manage cancer diagnoses and even the immune response following vaccinations. However, after vaccine administration, ACIP recommends use for fever treatment and local pain.

Immunization

European Pharmaceutical Review

SEPTEMBER 22, 2023

Active anti-Abeta immunotherapies In the 2000s, the concept of active immunotherapy targeting Abeta in Alzheimer’s patients was assessed with the ELAN vaccine (AN1792), consisting of full-length aggregated Abeta 1-42 peptide mixed with the QS21 adjuvant. 8 However, as this trial was not placebo-controlled, conclusions are difficult to draw.

Immunization

ISPE

MARCH 8, 2023

6 , 13 , 14 The most commonly mentioned contaminants were Burkholderia species 5 , 8 as a whole, and vesivirus 2117 for Genzyme products in 2009. Noteworthy cases were the inadvertent introduction of grade 316L stainless steel into Moder-na’s COVID-19 vaccine by the outsourced manufacturer (ROVI Pharma Industrial Services S.

Compounding

Pharmaceutical Technology

AUGUST 26, 2008

We are now one of the ten largest biopharma companies in the world with a rich armoury of new technology, comprising a full suite of technologies, small molecules, antibodies and vaccines to create new human medicines.” The blood pressure results are expected in the first half of 2009.

Pharmaceutical Companies

pharmaphorum

JULY 22, 2025

The SCOPE trial of SCIB1 and Scancells next-generation candidate iSCIB1+ show "excellent results encompassing efficacy, durability, immune responses and safety" when added to standard checkpoint inhibitor therapy for advanced melanoma untreatable with surgery, according to the company. Medical affairs is evolving.

Vaccines

pharmaphorum

JULY 10, 2025

The new data from the US Measles Tracker , hosted by the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health, suggests that the US is at risk of losing its measles elimination status, according to IVAC executive director William Moss, who co-leads the tracking project.

Vaccines

The Thyroid Pharmacist

NOVEMBER 8, 2024

After being diagnosed with Hashimoto’s in 2009, I spent a lot of time, money, and resources on trying to figure out my root cause. It is a comprehensive stool-based test that addresses a wide range of microbial targets (bacteria, opportunistic organisms, viruses, parasites, fungi, and normal flora), as well as immune and digestive markers.

Immunization